Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Article in Molecular Cancer (September 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Molecular Cancer (September 2024)
Article in Molecular Immunology (August 2024)
Article in International Journal of Molecular Sciences (August 2024)